Endpoints News· @endpts · X·· 5 天前AI 评分22
AI 导读
Ira Mellman 担心药企过早退出肿瘤免疫治疗的竞争。在 Parker 研究所,他正推动重振这一领域。https://endpoints.news/ira-mellman-wants-parker-institute-to-restore-cancer-immunotherapy/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Ira Mellman fears drugmakers are quitting the cancer immunotherapy fight early. At the Parker Institute, he's pushing to restore it. https://endpoints.news/ira-mellman-wants-parker-institute-to-restore-cancer-immunotherapy/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com